QUIDELORTHO CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
QUIDELORTHO CORP (QDEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 273.00 thousand shares for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-19
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-10-01 was 0.00 shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-07-02 was 170.00K shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-04-02 was 83.00K shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 273.00K shares, a 24.66% increase from fiscal 2024.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 219.00K shares, a 13.44% decline from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 253.00K shares, a 35.29% increase from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 187.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-28 | 273.00K shares 10-K · filed 2026-02-19 | |||
| 2024-12-29 | 219.00K shares 10-K · filed 2025-02-27 | |||
| 2023-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | 0.00 shares derived: sum of 2 quarters · filed 2024-08-01 | 170.00K shares derived: sum of 3 quarters · filed 2024-08-01 | 253.00K shares 10-K/A · filed 2024-08-01 |
| 2023-10-01 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 170.00K shares derived: sum of 2 quarters · filed 2023-11-02 | 253.00K shares 10-Q · filed 2023-11-02 | 240.00K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-07-02 | 170.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 253.00K shares 10-Q · filed 2023-08-09 | 240.00K shares derived: sum of 3 quarters · filed 2023-08-09 | 240.00K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-04-02 | 83.00K shares 10-Q · filed 2023-05-04 | 70.00K shares derived: sum of 2 quarters · filed 2023-05-04 | 70.00K shares derived: sum of 3 quarters · filed 2023-05-04 | |
| 2023-01-01 | -13.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -13.00K shares derived: sum of 2 quarters · filed 2023-02-23 | 187.00K shares 10-K · filed 2023-02-23 | |
| 2022-10-02 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | 200.00K shares 10-Q · filed 2022-11-04 | ||
| 2022-07-03 | 200.00K shares 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |